Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune Checkpoint Inhibitors Combined with Targeted Therapy: The Recent Advances and Future Potentials. | Cancers (Basel) | 2023 | 37345194 | PubTator, text mining | PubMed |
| Anti-Tumor Strategies by Harnessing the Phagocytosis of Macrophages. | Cancers (Basel) | 2023 | 37345054 | PubTator, text mining | PubMed |
| Dual targeting of TGF-β and PD-L1 inhibits tumor growth in TGF-β/PD-L1-driven colorectal carcinoma. | Life Sci | 2023 | 37336360 | PubTator, text mining | PubMed |
| An amino acid metabolism-based seventeen-gene signature correlates with the clinical outcome and immune features in pancreatic cancer. | Front Genet | 2023 | 37333498 | PubTator, text mining | PubMed |
| Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells. | J Hematol Oncol | 2023 | 37316891 | PubTator, text mining | PubMed |
| Identification of neoantigens and immunological subtypes in clear cell renal cell carcinoma for mRNA vaccine development and patient selection. | Aging (Albany NY) | 2023 | 37315301 | PubTator, text mining | PubMed |
| Tumour-associated macrophages as a potential target to improve natural killer cell-based immunotherapies. | Essays Biochem | 2023 | 37313600 | PubTator, text mining | PubMed |
| A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer. | Front Immunol | 2023 | 37313409 | PubTator, text mining | PubMed |
| Rituximab therapy in adults with steroid-dependent nephrotic syndrome. | Arch Med Sci | 2023 | 37313189 | PubTator, text mining | PubMed |
| NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential. | Int J Mol Sci | 2023 | 37298470 | PubTator, text mining | PubMed |
| Targeting Stage-Specific Embryonic Antigen 4 (SSEA-4) in Triple Negative Breast Cancer by CAR T Cells Results in Unexpected on Target/off Tumor Toxicities in Mice. | Int J Mol Sci | 2023 | 37298141 | PubTator, text mining | PubMed |
| A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer. | J Cancer Res Clin Oncol | 2023 | 37291405 | PubTator, text mining | PubMed |
| Effect of the 2020 hypersensitivity pneumonitis guideline on the pathologic diagnosis of interstitial pneumonia. | Sci Rep | 2023 | 37291357 | PubTator, text mining | PubMed |
| PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis. | J Immunother Cancer | 2023 | 37286305 | PubTator, text mining | PubMed |
| The potential of FCRL genes as targets for cancer treatment: insights from bioinformatics and immunology. | Aging (Albany NY) | 2023 | 37285836 | PubTator, text mining | PubMed |
| Development and nationwide validation of kidney graft injury markers using urinary exosomes and microvesicles (complete English translation of the Japanese version). | BMC Nephrol | 2023 | 37280521 | PubTator, text mining | PubMed |
| Immune landscape and prognostic immune-related signature in KRAS-mutated lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37279937 | PubTator, text mining | PubMed |
| Sjögren's syndrome: novel insights from proteomics and miRNA expression analysis. | Front Immunol | 2023 | 37275849 | PubTator, text mining | PubMed |
| The predictive effect of immune therapy and chemotherapy under T cell-related gene prognostic index for Gastric cancer. | Front Cell Dev Biol | 2023 | 37274740 | PubTator, text mining | PubMed |
| Machine learning applied in maternal and fetal health: a narrative review focused on pregnancy diseases and complications. | Front Endocrinol (Lausanne) | 2023 | 37274341 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=20